Skip to content
10-Q

Quarterly Report

LAVA MEDTECH ACQUISITION CORP.

0001213900-22-048028

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$391.03K
Cash And Equivalents Q2 2022 · Jun 30, 2022 $1.15M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $1.54M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$3.6M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$5.35M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$6.47M
Stockholders Equity Q2 2022 · Jun 30, 2021 $24K
Stockholders Equity Q2 2022 · Mar 31, 2021 −$1K
Current Liabilities Q2 2022 · Jun 30, 2022 $289.95K
Current Liabilities Q2 2022 · Dec 31, 2021 $130.23K
Total Liabilities Q2 2022 · Jun 30, 2022 $5.54M
Total Liabilities Q2 2022 · Dec 31, 2021 $8.9M
Current Assets Q2 2022 · Jun 30, 2022 $1.75M
Current Assets Q2 2022 · Dec 31, 2021 $2.2M
Total Assets Q2 2022 · Jun 30, 2022 $119.81M
Total Assets Q2 2022 · Dec 31, 2021 $120.3M
Sga Expense Q2 2022 · Jun 30, 2022 $300.51K
Sga Expense Q2 2022 · Jun 30, 2022 $700.68K
Sga Expense Q2 2022 · Jun 30, 2021 $1K
Net Income Q2 2022 · Jun 30, 2022 $1.75M
Net Income Q2 2022 · Jun 30, 2022 $2.87M
Net Income Q2 2022 · Mar 31, 2022 $1.12M
Net Income Q2 2022 · Jun 30, 2021 −$1K
Net Income Q2 2022 · Mar 31, 2021 −$1K